Biovivium Strategies’ Post

How do you plan early for commercialization, yet remain flexible in your clinical trials? Follow these tips to avoid additional testing, verify the production process, and document sterility and performance. For a holistic scale-up approach, read this article in the European Pharmaceutical Manufacturer magazine featuring our SVP, Research and Development, Bioscience Production, Nandu Deorkar, and our VP, Operations, Clinical Services, George Marquez, MBA, LSSBB. https://lnkd.in/ghmPUDzi

There are 3 critical changes that pharma and biotech companies can make to improve the probability of clinical trial success. Ozmosi will be revealing these 3 changes in a talk straight from its founder, Beau Bush, at Pharma CI this Thursday at 11:00: Next Gen Probability of Success, Inferences on Clinical Trial Design and Managing Your Data. He’ll share how Ozmosi’s next gen data platform with comprehensive pharmaceutical and biotech data helps companies make smart investment decisions in high-risk environments.

Get tips and exclusive insights to benefit your workflows and analyses by reading Sannova’s Essential Roadmap to Drug Development. With helpful tips for achieving higher sensitivity and specificity in PK testing, this whitepaper gives you an inside perspective on QC from a leading analytical contract research lab serving clients on the frontier of drug discovery. #pharma #biotech #contractanalyticaltesting #bionalytical #siRNA

Our Innovation Ecosystem unites academia’s deep understanding of disease biology with the pharmaceutical industry’s expertise in drug development. This model has led to the initiation of seven clinical trials for ALS with unprecedented speed over the last decade, propelling research from the bench to the bedside. #ALSResearch #ALS #EveryoneLives #ALSClinicalTrials

How do FDA and biopharmaceutical companies bridge the gap from regulatory science innovation to routine practice? Hear more from Donna Boyce, Pfizer’s head of Global Regulatory Sciences, and other FDA and industry leaders on the panel "This is Your Pilot Speaking" at 3:15 PDT in Room 6F of the San Diego Convention Center. Join the conversation on best practices for piloting new regulatory approaches - such as real-world evidence, model-informed drug development, and innovative clinical trial designs - and discuss what we can learn together. #DIA2024. 

What major #trends and market forces point the way to pharma’s #future? 🔹 The global pharmaceutical industry is facing a bold new era. With a growing appetite for advanced technologies applied to processes across the organization, life science companies are modernizing everything from clinical R&D to commercial product launches. 🔹 Powerful big pharma is partnering with agile biotechs to introduce exciting new treatments. 🔹 With so many forces at work, what are the essential pharmaceutical industry statistics you need to know in 2023? #pharma #biotech #trends #future #onlinecourses #SymmetricTraining

Find below our 2023 annual Report all the best to neglected patients !!

🚀 Exciting Trends in Clinical Trials! 🌐 Is the surge in decentralized clinical trials fueled by fierce competition and innovative partnership models? Dive into the dynamic landscape of pharmaceutical R&D with our latest Frost Radar. With over 6,000 molecules in clinical development and 11,000+ in preclinical phases, the pharma industry is buzzing with activity. In Asia-Pacific (APAC), small to mid-sized pharma/biotech players are stepping up their game, rivaling Europe in clinical trial participation. Discover more about APAC's booming contract research organization (CRO) sector and how it's shaping the future of clinical research. Download a sample of our Frost Radar here: https://frost.ly/9pp #ClinicalTrials #PharmaR&D #DecentralizedTrials #HealthcareInnovation #Frost&Sullivan #IndustryTrends

Are CROs an Unnecessary Expense? In this episode, Charles Theuer discusses the potential drawbacks of Clinical Research Organizations in pharmaceutical clinical development, and what can be done to improve it. Tune in to learn more about in-house trial management and how to improve efficiency and reduce costs in drug development by adopting alternative models to CROs! https://lnkd.in/eBEmPTr4 Click this link to the show notes, transcript, and resources: outcomesrocket.health Host: Joseph K. from ProofPilot #outcomesrocket #podcast #clinicalresearch #organization #development #pharmaceutical

In this on-demand webinar, our panel of experts discusses key findings from a survey of 150 leaders at #biotech and #pharmaceutical organizations around the world. Listen in to explore the implications of these trends for #drugdevelopers, and gain insights into R&D strategies and new technologies. » https://bit.ly/471cn4v